特别提示： 深圳市新产业生物医学工程股份有限公司（以下简称"公司"）于近日收到 公司持股 5%以上的股东天津红杉聚业股权投资合伙企业（有限合伙）（以下简 称"红杉聚业"或"天津红杉"）出具的《关于新产业减持计划的告知函》，以 及公司董事饶捷女士、公司高级管理人员刘海燕女士分别出具的《关于股份减持 计划的告知函》。 1、 红杉聚业于 2011 年完成对公司的投资，是公司自设立以来首轮融资中唯 一的创投机构，投资期长达 14 年。红杉聚业持有本公司股份 83,454,063 股（占 本公司总股本的 10.6214%），该部分股份已于 2023 年 5 月 12 日解除限售并上市 流通。红杉聚业计划自本减持计划公告之日起 15 个交易日后的 3 个月内通过大 宗交易方式减持本公司股份的数量不超过 14,500,000 股（按公司截至告知函出具 日的股份总数 785,718,785 股计算，对应的股份比例为不超过公司总股本的 1.8454%）。若在本减持计划公告日至减持时间区间届满日期间公司有送股、资 本公积金转增股本、配股等股份变动事项，减持股份数量进行相应调整。 2、 公司董事饶捷女士持有公司股份 24,466, ...

Group 1 - The company Shenzhen New Industry Biomedical Engineering Co., Ltd. has conducted a series of investor relations activities from September 1 to September 28, 2025 [1] - The activities included on-site visits, online communications, and strategy meetings with major financial institutions such as UBS and HSBC, involving a total of 38 institutions and 75 participants [1] - The company maintained a stable information disclosure rhythm, with no new major interactive content reported during this event, indicating consistent communication with investors [1]

Group 1: Event Overview - The investor relations activities took place from September 1 to September 28, 2025 [2] - The location of the activities was at the New Industry Biomedical Building, No. 23, Jinxiu East Road, Kengzi Street, Pingshan District, Shenzhen [2] - A total of 38 institutions participated, with 75 attendees [2] Group 2: Participants and Activities - The activities included on-site visits and various online strategy meetings with institutions such as UBS and HSBC [2] - Key personnel from the company included Chairman and General Manager Rao Wei, Deputy General Manager and Board Secretary Zhang Lei, and Investor Relations Head Lü Yuning [2] - No new major communication content was introduced beyond previously disclosed investor relations activities [2] Group 3: Attending Institutions - Notable participating institutions included AllianceBernstein, DawnLight Capital, and Polar Capital [3] - Other participants included various fund management companies such as Southern Fund Management and Ping An Pension Insurance [3][4]

Group 1 - On September 30, a total of 360,000 shares of New Industry were traded in block transactions, with a transaction value of 24.588 million yuan, accounting for 11.12% of the total transaction value for the day [1] - The transaction price was 68.3 yuan, which remained stable compared to the market closing price of 68.3 yuan [1] - The block transactions included two separate trades, one for 200,000 shares valued at 13.66 million yuan and another for 160,000 shares valued at 10.928 million yuan, both executed by institutional investors [2]

Core Insights - The conference focused on three main areas: "Good Housing," "Urban Renewal," and "Science and Technology Innovation Industry" [1] - Over a hundred innovative construction technology products were showcased at the event [1] - Discussions included topics such as intelligent construction, intelligent design, and industry-academia-research collaboration [1] Company Highlights - China State Construction Engineering Corporation's Eighth Engineering Bureau released solutions for urban renewal, intelligent construction, and green low-carbon technology innovations [1] Industry Developments - The event featured an exhibition showcasing innovations in construction industrialization, intelligent construction, green low-carbon technologies, digital industries, and new building materials [1]

Core Viewpoint - The application of artificial intelligence (AI) in Shenzhen New Industry Biomedical Engineering Co., Ltd. has significantly enhanced efficiency and reduced costs in the in vitro diagnostic product sector, providing a competitive edge in the market [1][2]. Group 1: AI Efficiency and Cost Reduction - AI technology has improved data collection efficiency by 10 times and reduced data processing time by 70%, allowing for quicker analysis and decision-making [9]. - The SATLARS T8 system, developed by the company, has been installed in over 200 hospitals, with more than 50% being tertiary hospitals, significantly shortening sample turnaround times [3]. - The automated processing system can enhance detection efficiency by over 30% through AI-driven sample quality assessment and intelligent scheduling [8]. Group 2: Market Landscape and Opportunities - The in vitro diagnostic market in China is dominated by multinational companies, holding 71.2% of the immunodiagnostic market and 53.2% of the biochemical diagnostic market [2]. - The global in vitro diagnostic market is projected to reach $109.2 billion by 2024, with emerging markets like China and India experiencing rapid growth [2]. Group 3: R&D and Innovation - The company is leveraging AI to analyze vast amounts of experimental data, which aids in the development of new reagents and reduces the traditional trial-and-error approach [10]. - AI is expected to shorten the development cycle of new reagent process parameters by over 50%, enhancing the company's responsiveness to market demands [10]. - The company aims to build a proprietary research knowledge graph based on accumulated structured internal data, transforming AI from an efficiency enhancer to an innovation driver in product development [10]. Group 4: Financial Performance - In the first half of the year, the company achieved a revenue of 2.185 billion yuan and a net profit of 771 million yuan [10].

2025年8月，暑期消费的火热浪潮为广州经济注入澎湃动力，流量经济保持活跃，供需两端部分领域加 快恢复改善，广州经济运行总体平稳，新动能新产业更是如雨后春笋般不断壮大，为城市发展注入源源 不断的新动力。 新能源车累计产量增长14.3%，民用无人机产量提速增长52.5%，工业投资保持两位数快速增长；国际 航线旅客吞吐量快速增长21.2%……9月24日，广州市统计局公布2025年前8个月广州经济运行情况。 工业"新"潮涌动 今年8月，小鹏汽车共交付新车37709辆，同比增长169%，环比增长3%，单月交付量再创历史新高；广 汽领程新能源重卡T9正式下线，主要聚焦港口、矿区、钢厂等短途高频运输场景……今年以来，广州 新能源汽车产销逐步加快。 广州市统计局数据显示，今年1—8月，全市规模以上工业增加值同比持平。重点行业中，汽车制造业承 压改善，实现工业增加值下降5.3%，降幅比1—7月收窄0.9个百分点，产业转型新动能稳步释放，新能 源车累计产量增长14.3%。 传统行业转型升级，新兴领域蓬勃兴起。8月15日，盛世翼行（广东）航空科技有限公司重载无人机展 销中心正式开业，公司将在黄埔区中集大湾区国际人才创业园建设重载 ...

"在中瑞经贸往来中，我过去一直致力于协助中国企业到瑞士落地，也协助瑞士企业来华投资与发展。在这个过程中，我曾经为双方企业提供过市场调研、 市场准入、合规咨询以及落地支持等一系列服务，也为他们链接可以提供专业法律和财务方面的专业咨询机构，几乎全程陪伴这些企业完成在瑞士的落地工 作。"孙科说，"这项工作已持续近20年，我也亲身见证了中国企业'走出去'的历程。" 孙科认为，尽管中国企业出海已有多年历史，但不同行业、不同规模的企业进入不同国家时仍会面临各种新的挑战。出海企业的目标各有不同，有些是为了 开拓新市场，有些是为了寻求新的技术合作，也有些是为了降低生产成本。因此，不同类型的企业所面临的挑战也各不相同。 中国商报（记者 赵熠如 文/图）9月23日，瑞士创新产业园首席代表、中国瑞士商会董事（北京）孙科在接受中国商报记者采访时表示，在中瑞经济合作 中，一些新兴产业值得双方共同关注和投资，生命科学、人工智能、高端智能制造是中瑞产业优势交叉点。 据悉，瑞士创新产业园长期致力于为企业打造顶尖研发和科技合作生态系统。2019年，瑞士创新产业园正式开始拓展中国市场，积极探索与中国出海企业在 生命科学、高端智能制造、移动出行和 ...

新产业所属申万行业为：医药生物-医疗器械-体外诊断。所属概念板块包括：价值成长、高派息、基金 重仓、MSCI中国、社保重仓等。 截至6月30日，新产业股东户数1.56万，较上期减少19.09%；人均流通股43743股，较上期增加23.59%。 2025年1月-6月，新产业实现营业收入21.85亿元，同比减少1.18%；归母净利润7.71亿元，同比减少 14.62%。 分红方面，新产业A股上市后累计派现38.60亿元。近三年，累计派现23.57亿元。 9月25日，新产业盘中上涨2.06%，截至10:13，报67.85元/股，成交6944.25万元，换手率0.15%，总市值 533.11亿元。 资金流向方面，主力资金净流入225.47万元，大单买入1306.34万元，占比18.81%，卖出1080.88万元， 占比15.57%。 新产业今年以来股价跌2.44%，近5个交易日跌1.05%，近20日涨15.00%，近60日涨23.07%。 资料显示，深圳市新产业生物医学工程股份有限公司位于广东省深圳市坪山区坑梓街道金沙社区锦绣东 路23号新产业生物大厦，成立日期1995年12月15日，上市日期2020年5月12日，公 ...

Group 1 - The core viewpoint of the article highlights the development of the tourism industry in Zhangguang Village, which is set to begin operations during the National Day holiday, with a trial revenue of nearly 40,000 yuan in one month [1] - The town of Gangmuda, where Zhangguang Village is located, aims to build a high-quality urban-rural integration development system, with the town serving as the core of this initiative [1] - The article discusses the establishment of a dairy product company in Yangpei Village, which produces fresh milk, yogurt, and whey to supply local dining establishments and government canteens [1] Group 2 - Mingda Village has formed a labor service company to stabilize employment for villagers, with monthly incomes for participants reaching between 4,000 to 6,000 yuan [1] - To enhance the effectiveness of linking farmers with agricultural projects, Gangmuda Town has involved village collectives and residents in equity participation in three cultivated projects, ensuring long-term stability and profit-sharing [2]